We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.2B
AUM Growth
+$172M
Cap. Flow
-$1.31B
Cap. Flow %
-3.26%
Top 10 Hldgs %
18.88%
Holding
794
New
108
Increased
186
Reduced
363
Closed
91

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$263M
2
DD icon
DuPont de Nemours
DD
+$238M
3
WMT icon
Walmart Inc
WMT
+$216M
4
ROST icon
Ross Stores
ROST
+$195M
5
FTV icon
Fortive
FTV
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Technology 15.21%
3 Financials 12.82%
4 Consumer Discretionary 11.4%
5 Industrials 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTW icon
626
Manitowoc
MTW
$491M
$4.45M 0.01%
+250,248
New +$4.15M
ZM icon
627
Zoom
ZM
$27.1B
$4.44M 0.01%
+50,000
New +$4.11M
CHNG
628
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$4.38M 0.01%
+300,000
New +$4.44M
NEM icon
629
Newmont
NEM
$96.2B
$4.34M 0.01%
112,956
-542,044
-83% -$18.3M
XPRO icon
630
Expro Ltd
XPRO
$1.64B
$4.26M 0.01%
130,141
-33,333
-20% -$1.2M
RETA
631
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.25M 0.01%
+45,000
New +$3.89M
QRVO icon
632
Qorvo
QRVO
$7.9B
$4.21M 0.01%
63,278
-61,300
-49% -$4.26M
DINO icon
633
HF Sinclair
DINO
$16.2B
$3.96M 0.01%
85,600
-109,900
-56% -$4.91M
MXIM
634
DELISTED
Maxim Integrated Products
MXIM
$3.92M 0.01%
65,600
-152,100
-70% -$8.67M
ICD
635
DELISTED
Independence Contract Drilling, Inc.
ICD
$3.92M 0.01%
123,935
HSKA
636
DELISTED
Heska Corp
HSKA
$3.83M 0.01%
+45,000
New +$3.51M
BBWI icon
637
Bath & Body Works
BBWI
$3.97B
$3.81M 0.01%
+180,512
New +$3.57M
ATI icon
638
ATI
ATI
$24.3B
$3.78M 0.01%
+150,000
New +$3.66M
SLCA
639
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$3.68M 0.01%
287,546
+50,000
+21% +$682K
SAGE
640
DELISTED
Sage Therapeutics
SAGE
$3.66M 0.01%
20,000
BWA icon
641
BorgWarner
BWA
$12.8B
$3.65M 0.01%
+98,832
New +$3.5M
BRY
642
DELISTED
Berry Corp
BRY
$3.39M 0.01%
320,000
+50,000
+19% +$567K
UNM icon
643
Unum
UNM
$13.2B
$3.33M 0.01%
99,269
+56,700
+133% +$1.96M
HSIC icon
644
Henry Schein
HSIC
$9.78B
$3.27M 0.01%
46,800
-9,400
-17% -$621K
ZSAN
645
DELISTED
Zosano Pharma Corporation
ZSAN
$3.27M 0.01%
28,571
IFF icon
646
International Flavors & Fragrances
IFF
$20.3B
$3.16M 0.01%
21,800
-1,700
-7% -$236K
FTSI
647
DELISTED
FTS International, Inc. Common Stock
FTSI
$3.15M 0.01%
28,250
-10,000
-26% -$1.65M
STIM icon
648
Neuronetics
STIM
$127M
$3.13M 0.01%
+250,000
New +$3.53M
STLD icon
649
Steel Dynamics
STLD
$36.2B
$3.02M 0.01%
+100,000
New +$3.06M
AORT icon
650
Artivion
AORT
$1.34B
$2.99M 0.01%
+100,000
New +$2.97M

Similar funds

Adage Capital Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Adage Capital Partners held 794 positions worth $40.2B, up 0.43% from $40B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Adage Capital Partners withdrew a net $1.31B in Q2 2019, closing 91 positions and reducing 363 holdings. Its most notable exit was InflaRx, an estimated $85.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Adage Capital Partners opened a new position in Raytheon Company worth $186M.

  • Adage Capital Partners's largest Q2 2019 buy was Raytheon Company: 1,071,108 shares worth $186M.
  • Adage Capital Partners added most to Celgene Corp in Q2 2019, an estimated $427M increase.
  • Adage Capital Partners's biggest Q2 2019 reduction was Honeywell, cutting an estimated $263M.
  • Adage Capital Partners fully exited InflaRx in Q2 2019, selling an estimated $85.9M.
  • Adage Capital Partners's ten largest holdings make up 19% of its $40.2B portfolio in Q2 2019.
  • Adage Capital Partners opened 108 new positions and closed 91 in Q2 2019.
  • Adage Capital Partners's portfolio value rose 0.43% quarter-over-quarter to $40.2B.

Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.